Ingevity Corporation (NYSE:NGVT) Receives Average Recommendation of “Hold” from Brokerages

Shares of Ingevity Corporation (NYSE:NGVT) have been given a consensus recommendation of “Hold” by the five brokerages that are covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and two have issued a buy recommendation on the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $80.00.

A number of research analysts have issued reports on NGVT shares. Weiss Ratings reiterated a “sell (d-)” rating on shares of Ingevity in a research report on Tuesday, April 21st. Wall Street Zen lowered Ingevity from a “strong-buy” rating to a “buy” rating in a research report on Monday.

Insider Transactions at Ingevity

In other Ingevity news, SVP Terrance M. Dyer sold 496 shares of the business’s stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $68.49, for a total transaction of $33,971.04. Following the completion of the transaction, the senior vice president owned 7,202 shares in the company, valued at approximately $493,264.98. The trade was a 6.44% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 0.88% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in NGVT. AQR Capital Management LLC boosted its position in Ingevity by 10.9% during the 1st quarter. AQR Capital Management LLC now owns 13,410 shares of the company’s stock worth $518,000 after acquiring an additional 1,323 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Ingevity by 5.2% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,790 shares of the company’s stock worth $863,000 after buying an additional 1,080 shares in the last quarter. Empowered Funds LLC raised its stake in shares of Ingevity by 12.9% in the 1st quarter. Empowered Funds LLC now owns 5,181 shares of the company’s stock worth $205,000 after buying an additional 594 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of Ingevity by 311.8% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 600,380 shares of the company’s stock worth $23,769,000 after buying an additional 454,579 shares in the last quarter. Finally, Jane Street Group LLC raised its stake in shares of Ingevity by 306.1% in the 1st quarter. Jane Street Group LLC now owns 88,883 shares of the company’s stock worth $3,519,000 after buying an additional 66,995 shares in the last quarter. Institutional investors and hedge funds own 91.59% of the company’s stock.

Ingevity Price Performance

Shares of NGVT opened at $74.92 on Wednesday. The company has a market cap of $2.60 billion, a P/E ratio of -21.10 and a beta of 1.18. The stock has a fifty day moving average price of $71.37 and a 200 day moving average price of $68.90. The company has a debt-to-equity ratio of 27.83, a current ratio of 1.42 and a quick ratio of 0.92. Ingevity has a 12 month low of $39.74 and a 12 month high of $79.29.

Ingevity (NYSE:NGVT) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $1.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.84 by $0.31. Ingevity had a positive return on equity of 207.82% and a negative net margin of 10.55%.The company had revenue of $258.00 million during the quarter, compared to analyst estimates of $254.73 million. During the same quarter in the previous year, the firm posted $1.01 EPS. The firm’s quarterly revenue was up 4.1% on a year-over-year basis. Ingevity has set its FY 2026 guidance at 4.700-5.200 EPS. On average, research analysts forecast that Ingevity will post 5.05 earnings per share for the current year.

Ingevity Company Profile

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.